INVA vs BIIB: Which Stock is Better?

Side-by-side comparison of Innoviva Inc and Biogen Inc in 2026

Comparison Updated:

INVA

Innoviva Inc

$24.24

BIIB

Biogen Inc

$177.35

Key Metrics Comparison

MetricINVABIIBWinner
Market Cap$1.76B$26.03BBIIB
P/E Ratio7.1520.04INVA
EPS (TTM)$3.30$8.85BIIB
Revenue Growth0.2%-0.1%INVA
Gross Margin74.9%78.9%BIIB

Analyze INVA

Full quant analysis

Analyze BIIB

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is INVA or BIIB a better investment?

Comparing INVA and BIIB: Innoviva Inc has a market cap of $1.76B while Biogen Inc has $26.03B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between INVA and BIIB?

INVA (Innoviva Inc) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: INVA or BIIB?

Based on P/E ratios, INVA trades at a lower multiple (7.2x vs 20.0x).

Which is growing faster: INVA or BIIB?

INVA has higher revenue growth at 0.2% vs -0.1% for BIIB.

Which company is more profitable: INVA or BIIB?

Biogen Inc (BIIB) has higher gross margins at 78.9% compared to 74.9% for INVA.

Which is the larger company: INVA or BIIB?

Biogen Inc (BIIB) is larger with a market cap of $26.03B compared to $1.76B for INVA.

Should I buy INVA or BIIB in 2026?

Both INVA and BIIB have investment merit. INVA trades at $24.24 while BIIB trades at $177.35. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between INVA and BIIB stock?

Key differences: Market Cap ($1.76B vs $26.03B), P/E Ratio (7.2x vs 20.0x), Revenue Growth (0.2% vs -0.1%), Gross Margin (74.9% vs 78.9%).

Popular Stock Comparisons